Susquehanna International Group’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.38M | Buy |
299,973
+46,474
| +18% | +$989K | ﹤0.01% | 1077 |
|
|
2025
Q1 | $4.89M | Buy |
253,499
+176,275
| +228% | +$3.4M | ﹤0.01% | 1245 |
|
|
2024
Q4 | $1.38M | Sell |
77,224
-289,171
| -79% | -$5.16M | ﹤0.01% | 2503 |
|
|
2024
Q3 | $8.02M | Buy |
366,395
+112,594
| +44% | +$2.47M | ﹤0.01% | 759 |
|
|
2024
Q2 | $1.98M | Buy |
253,801
+92,463
| +57% | +$721K | ﹤0.01% | 1778 |
|
|
2024
Q1 | $668K | Sell |
161,338
-69,012
| -30% | -$286K | ﹤0.01% | 3137 |
|
|
2023
Q4 | $601K | Buy |
230,350
+103,979
| +82% | +$271K | ﹤0.01% | 3584 |
|
|
2023
Q3 | $236K | Sell |
126,371
-252,971
| -67% | -$473K | ﹤0.01% | 4325 |
|
|
2023
Q2 | $952K | Sell |
379,342
-1,309,223
| -78% | -$3.29M | ﹤0.01% | 2782 |
|
|
2023
Q1 | $2.95M | Buy |
1,688,565
+1,408,141
| +502% | +$2.46M | ﹤0.01% | 1542 |
|
|
2022
Q4 | $1.19M | Buy |
280,424
+198,717
| +243% | +$845K | ﹤0.01% | 2130 |
|
|
2022
Q3 | $97K | Buy |
81,707
+58,070
| +246% | +$68.9K | ﹤0.01% | 5293 |
|
|
2022
Q2 | $24K | Buy |
+23,637
| New | +$24K | ﹤0.01% | 5387 |
|
|
2022
Q1 | – | Sell |
-14,461
| Closed | -$39K | – | 6449 |
|
|
2021
Q4 | $39K | Buy |
14,461
+1,641
| +13% | +$4.43K | ﹤0.01% | 5528 |
|
|
2021
Q3 | $64K | Buy |
+12,820
| New | +$64K | ﹤0.01% | 5056 |
|
|
2021
Q2 | – | Sell |
-133,808
| Closed | -$785K | – | 5871 |
|
|
2021
Q1 | $785K | Buy |
133,808
+105,922
| +380% | +$621K | ﹤0.01% | 3298 |
|
|
2020
Q4 | $131K | Buy |
+27,886
| New | +$131K | ﹤0.01% | 4418 |
|
|
2019
Q4 | – | Sell |
-26,491
| Closed | -$47K | – | 4726 |
|
|
2019
Q3 | $47K | Buy |
+26,491
| New | +$47K | ﹤0.01% | 4208 |
|
|
2019
Q1 | – | Sell |
-10,569
| Closed | -$12K | – | 4372 |
|
|
2018
Q4 | $12K | Buy |
+10,569
| New | +$12K | ﹤0.01% | 3488 |
|
|
2017
Q4 | – | Sell |
-146,000
| Closed | -$1.83M | – | 4424 |
|
|
2017
Q3 | $1.83M | Buy |
+146,000
| New | +$1.83M | ﹤0.01% | 1152 |
|